STEVEN FOWLER: Open Payments
NPI 1508817628 · TAYLOR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 63 payments from 13 companies in 2025. Trend: 2023 $1,694 · 2024 $1,613 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $221 |
| GENZYME CORPORATION | 5 | $196 |
| PFIZER INC. | 9 | $188 |
| ABBVIE INC. | 9 | $187 |
| Novartis Pharmaceuticals Corporation | 5 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| UCB, Inc. | 3 | $62 |
| Amgen Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $45 |
Products named: DUPIXENT, TREMFYA, CIBINQO, Sotyktu, RINVOQ, SKYRIZI, Bimzelx, OTEZLA.
Industry payments across TX — which companies pay providers there.
